ARCHIVES

Interview with Christine Berg: ST Findings Relevant Only To High-Risk;

This article is from The Cancer Letter archive.

Vol. 36 No. 43 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

In Brief: alberts elected To Second Term as NAS President

February 19, 1999

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000

FDA Advisors Okay DDC For AIDS Treatment In Comb With AZT

May 8, 1992

Duke Researchers Retract Paper from Blood; Dozens of Retractions of Potti’s Work Expected

September 9, 2011

Cancer Research Institute Goes To Wall Street

January 17, 1986